Biologics include some of the most innovative and expensive drugs today. They also raise some of the more complex intellectual property (IP) strategies. Patents provide exclusivity in national markets for the molecules, and trade secrecy shrouds the complex, secret manufacturing processes.
-
12May
-
16Mar
The 2023 Baron de Lancey Lecture - Assisted Dying: Slippery Slopes and Unintended Consequences
Prof. Emily Jackson (London School of Economics)
-
20Sep
This Dissemination event presents the findings from a THIS (The Healthcare Improvement Studies) Institute interdisciplinary fellowship, held at the University of Cambridge.
-
16Sep
Repurposing, the idea of finding new treatments for already authorised drugs, presents significant advantages for drug development. Modern drug development is hindered by high costs and research that takes over a decade. Repurposing is a potential solution to these problems because it is cheaper, faster and safer than developing new compounds.
-
10Jun
On 10 June 2022, Dr John Liddicoat (LML Senior Research Associate) will present his paper ‘Repositioning Generic Drugs: Empirical Realities’ at the Munich Summer Institute. Only 8.5% of papers submitted to this conference are accepted for presentations.
-
19May
On Thursday 19 May 2022, Dr Caterina Milo will present at an online webinar, organised by the University of Cambridge's Reproduction SRI.
-
25Apr
On Monday 25 April 2022, Dr John Liddicoat (LML Senior Research Associate) will participate in Patent Repositioning for rare diseases – too much, too little or just right?, a webinar organised by the Nordic Intellectual Property Review.
-
10Mar
The 2022 Baron de Lancey Lecture - Re-engineering the Regulation of Regenerative Medicine?
Prof. Bartha Maria Knoppers - Centre for Genomics and Policy, McGill University
-
11Feb
On Friday 11 February 2022, Prof. Angus Corbett (LML Visiting Scholar) will deliver the talk 'The Interaction between the Law concerning Decision Making and Consent and the Dynamics of the Health System'.
-
04Nov
On Thursday 4 November 2021, Dr Caterina Milo will deliver a Cambridge Socio-Legal Group Webinar on 'Covid-19 Vaccines and the Role of Informed Consent'.